{"id":465780,"date":"2025-12-23T03:46:12","date_gmt":"2025-12-23T03:46:12","guid":{"rendered":"https:\/\/www.europesays.com\/us\/465780\/"},"modified":"2025-12-23T03:46:12","modified_gmt":"2025-12-23T03:46:12","slug":"wegovy-pill-approved-by-us-fda-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/465780\/","title":{"rendered":"Wegovy pill approved by US FDA for weight loss"},"content":{"rendered":"

The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to <\/b>pharmaceutical giant Novo Nordisk.<\/p>\n

It is the first pill of its kind to receive approval from the regulator, marking a new era for weight-loss drugs.<\/p>\n

Wegovy’s Danish makers Novo Nordisk said the once-daily pill was a “convenient option” to the injectable <\/b>and would provide the same weight loss as the shot. It comes after Wegovy was approved by the FDA specifically for weight loss.<\/p>\n

Others like Ozempic, which has similar weight-loss effects, were primarily approved for the treatment of Type 2 diabetes.<\/p>\n

The BBC has contacted the FDA for comment.<\/p>\n

The Wegovy pill showed an average weight loss of 16.6% during Novo Nordisk’s trials, the firm said<\/a> on Monday.<\/p>\n

A third of around 1,300 participants experienced 20% or greater weight loss in the same trial, it added.<\/p>\n

The pill is expected to be launched in the US in early January 2026.<\/p>\n

“Patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” said Mike Doustdar, the firm’s chief executive.<\/p>\n

The pill version of Wegovy could give Novo Nordisk’s sales a boost after a challenging year which saw its shares slide as it warned over its profits.<\/p>\n

The company has faced intense competition in the weight-loss market from rival drugmakers like Eli Lilly.<\/p>\n

Novo Nordisk’s shares rose by almost 10% in after-hours trade in New York after the announcement.<\/p>\n","protected":false},"excerpt":{"rendered":"The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according…\n","protected":false},"author":3,"featured_media":465781,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-465780","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115766832994143646","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/465780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=465780"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/465780\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/465781"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=465780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=465780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=465780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}